Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The N-Glycosylation of Total Plasma Proteins and IgG in Atrial Fibrillation.
Biomolecules. 2023 Mar 28;13(4):605. doi: 10.3390/biom13040605.
Biomolecules. 2023.
PMID: 37189353
Free PMC article.
Is the extent of left atrial fibrosis associated with body mass index in patients undergoing pulmonary vein isolation for atrial fibrillation?
Nossan JS, Šesto I, Štambuk K, Šipić T, Bernat R, Gudelj I, Rotkvić L, Žulj M, Mirat J.
Nossan JS, et al. Among authors: sesto i.
Kardiol Pol. 2021;79(5):531-538. doi: 10.33963/KP.15910.
Kardiol Pol. 2021.
PMID: 34125926
Free article.
Item in Clipboard
Item in Clipboard
Relationship of genetic markers for atherosclerosis and long-term outcome after percutaneous coronary intervention with stenting.
Bernat R, Szavits-Nossan J, Trbović A, Kapov-Svilicić K, Sesto I, Sipić T.
Bernat R, et al. Among authors: sesto i.
Coll Antropol. 2012 Dec;36(4):1385-90.
Coll Antropol. 2012.
PMID: 23390838
Item in Clipboard
Angiographic control and percutaneous treatment of myocardial ischemia immediately after CABG.
Szavits-Nossan J, Stipić H, Sesto I, Kapov-Svilicić K, Sipić T, Bernat R.
Szavits-Nossan J, et al. Among authors: sesto i.
Coll Antropol. 2012 Dec;36(4):1391-4.
Coll Antropol. 2012.
PMID: 23390839
Item in Clipboard
The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
Roguljić H, Arambašić J, Ninčević V, Kuna L, Šesto I, Tabll A, Smolić R, Včev A, Primorac D, Wu GY, Smolić M.
Roguljić H, et al. Among authors: sesto i.
Croat Med J. 2022 Jun 22;63(3):287-294. doi: 10.3325/cmj.2022.63.287.
Croat Med J. 2022.
PMID: 35722697
Free PMC article.
Item in Clipboard
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.
Ridker PM, et al.
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
N Engl J Med. 2017.
PMID: 28845751
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite